(Q36641440)

15 August 2017

Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection (English)

1 reference

15 August 2017

1 reference

1 reference

Heriot AG

1

1 reference

15 August 2017

Marriott JB

2

1 reference

15 August 2017

Cookson S

3

1 reference

15 August 2017

Kumar D

4

1 reference

15 August 2017

Dalgleish AG

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

82

1 reference

15 August 2017

5

1 reference

15 August 2017

1009-1012

1 reference

https://scigraph.springernature.com/pub.10.1054/bjoc.1999.1034

15 August 2017

0 references

cites work

Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374422

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374422

Need for immunologic stimulators during immunosuppression produced by major cancer surgery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374422

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374422

The role of immunotherapy for urological tumours

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374422

Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374422

Impaired cytokine production in whole blood cell cultures from patients with colorectal carcinomas as compared to benign colorectal tumors and controls

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374422

Analysis of T Helper and Suppressor Lymphocyte Subsets in Relation to the Clinical Stage of Solid Neoplasms

28 June 2018

1 reference

12 December 2020

Influence of preoperative treatment and surgical operation on immune function of patients with esophageal carcinoma

1 reference

12 December 2020

Duration of postoperative immunosuppression assessed by repeated delayed type hypersensitivity skin tests

1 reference

12 December 2020

Flow cytometric study of lymphocyte subsets in patients at different stages of colorectal carcinoma

1 reference

12 December 2020

A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates

1 reference

12 December 2020

Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients

1 reference

12 December 2020

Prospective study of circulating T-lymphocyte subpopulations and disease progression in colorectal cancer

1 reference

12 December 2020

High serum carcinoembryonic antigen concentration in patients with colorectal liver metastases is associated with poor cell-mediated immunity, which is predictive of survival

1 reference

12 December 2020

Impaired interleukin-12 production is associated with a defective anti-tumor response in colorectal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.1999.1034

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

10737381

1 reference